Hormone Therapy Market Report 2026

Hormone Therapy Market Overview

• Hormone Therapy market size has reached to $20.9 billion in 2025 • Expected to grow to $29.93 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Rising Aging Population Fuels Growth In The Hormone Therapy Market • Market Trend: Innovative Direct-To-Consumer Telehealth Solutions Revolutionizing Hormone Therapy Accessibility • North America was the largest region in 2025.

What Is Covered Under Hormone Therapy Market?

Hormone therapy refers to a kind of treatment that alters, suppresses, or increases certain hormones in the body. Hormone therapy is used to treat hormonal imbalances such as hypothyroidism, and others. The main therapies of hormone therapy are estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy refers to treatment with the hormone estrogen to boost the body's level of estrogen. Oral, parenteral, and other routes of administration are used in indications such as menopause, hypothyroidism, growth hormone deficiency, and others, with distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Hormone Therapy Market Growth Forecast?

The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $29.93 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to aging global population, growth in menopause-related treatments, increasing focus on quality of life therapies, expansion of online pharmacies, ongoing innovation in hormone delivery systems. Major trends in the forecast period include rising adoption of personalized hormone regimens, growing demand for bioidentical hormones, expansion of hormone therapy in aging populations, increased use of combination hormone therapies, shift toward convenient and long-acting formulations.

Global Hormone Therapy Market Segmentation

1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement 2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications 4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies Subsegments: 1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy 2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones 3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid 4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets

What Is The Driver Of The Hormone Therapy Market?

The increasing number of elderly individuals is expected to propel the growth of the hormone therapy market in the coming years. Aged individuals are people who are in their later phases of life and are frequently connected with older people or the senior population. Hormone treatment in the elderly, particularly in the context of aging-related health disorders, aims to correct hormonal imbalances and manage specific aging-related illnesses. For instance, in July 2024, according to the UK Parliament, a UK-based government body, the population of the UK is expected to reach 70 million by 2026. Additionally, the population is aging, with 19% of people aged 65 or over in 2022. This figure is projected to rise to 27% by 2072. Therefore, the increasing number of elderly individuals is driving the hormone therapy industry.

Key Players In The Global Hormone Therapy Market

Major companies operating in the hormone therapy market are Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited

Global Hormone Therapy Market Trends and Insights

Major companies operating in the hormone therapy market are focusing on developing innovative solutions, such as direct-to-consumer telehealth models for hormone therapy, to enhance accessibility and convenience for patients. The direct-to-consumer telehealth model for hormone therapy refers to a healthcare delivery system that allows patients to access hormone therapy services remotely, without the need for traditional in-person consultations. For instance, in September 2023, LifeMD, a US-based telehealth company, partnered with ASCEND Therapeutics, a US-based pharmaceutical company, to launch an integrated direct-to-consumer telehealth model for hormone therapy, focusing on EstroGel (estradiol gel) to alleviate menopausal symptoms. This partnership allows patients to access LifeMD's telehealth services directly through the EstroGel website, facilitating consultations with licensed healthcare providers who can prescribe the medication and arrange home delivery. By streamlining access and addressing barriers such as long wait times, the initiative aims to enhance health outcomes for women seeking menopause treatment.

What Are Latest Mergers And Acquisitions In The Hormone Therapy Market?

In January 2024, Biote Corp, a US-based provider of personalized hormone-optimization and therapeutic-wellness solutions, acquired Asteria Health for US$ 8.5 million. With this acquisition, Biote strengthened its vertical integration by gaining 503B manufacturing capacity, thereby securing its supply chain and improving operational efficiency. Asteria Health, a US-based company, operates an FDA-registered 503B outsourcing facility specializing in the compounding of bioidentical hormones for Biote-certified clinics.

Regional Insights

North America was the largest region in the hormone therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hormone Therapy Market?

The hormone therapy market includes revenues earned by entities by providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hormone Therapy Market Report 2026?

The hormone therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hormone therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.